buyWeak
David Ross Parkinson bought $21k of EPIX
Chief Executive Officer at ESSA Pharma Inc.. 9,223 shares at an average of $2.30, traded Dec 14, 2023, filed Dec 18, 2023.
Conviction score
28Value
$21k
9,223 shares
Holdings after
65,675
+16% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- 0Trade size$21k at market
- +3Relative to holdingsHoldings up 16%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-23-071270, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 14, 2023 | POpen-market purchase Common Shares | +9,223 | $2.30 | $21k | 65,675 | Dec 18, 2023 |
Related signals
Other insiders at ESSA Pharma Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 12Weak | EPIXsell ESSA Pharma Inc. | Bvf Partners L P/il owner | $293 156 shares | -0% | |
| 57Moderate | EPIXsell ESSA Pharma Inc. | Biotech Growth N V owner | $12M 7,879,583 shares | -100% | |
| 0Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $4,164 694 shares | -8% | |
| 5Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $13k 2,082 shares | -19% | |
| 0Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $4,823 694 shares | -6% | |
| 0Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $5,510 694 shares | -5% | |
| 0Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $6,232 694 shares | -5% | |
| 26Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $749k 72,782 shares | -85% | |
| 0Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $11k 1,194 shares | -9% | |
| 0Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $17k 1,718 shares | -11% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.